Race

Oral anticoagulants including warfarin, coumadin, and anisindione (SHHS1) vs SHHS Visit Number
Visit 1 Visit 2 CVD Outcomes
Total 5,804 4,080 5,042
No 5,653 - -
Yes 133 - -
Unknown 18 4,080 5,042
Oral anticoagulants including warfarin, coumadin, and anisindione (SHHS1) vs Age at SHHS1
Visit 1
39.0 to 55.0 years 55.0 to 63.0 years 63.0 to 72.0 years 72.0 to 100.0 years Total
Total 1,451 1,451 1,451 1,451 5,804
No 1,434 1,439 1,408 1,372 5,653
Yes 7 9 43 74 133
Unknown 10 3 - 5 18
Oral anticoagulants including warfarin, coumadin, and anisindione (SHHS1) vs Gender
Visit 1
Female Male Total
Total 3,039 2,765 5,804
No 2,984 2,669 5,653
Yes 48 85 133
Unknown 7 11 18
Oral anticoagulants including warfarin, coumadin, and anisindione (SHHS1) vs Gender
Visit 2
Female Male Total
Total 2,219 1,861 4,080
No - - -
Yes - - -
Unknown 2,219 1,861 4,080
Oral anticoagulants including warfarin, coumadin, and anisindione (SHHS1) vs Race
Visit 1
white black native amer/alaskan asian/pacific islander hispanic/mex. amer other Total
Total 4,907 515 11 88 280 3 5,804
No 4,776 503 10 85 276 3 5,653
Yes 121 7 1 2 2 - 133
Unknown 10 5 - 1 2 - 18
Oral anticoagulants including warfarin, coumadin, and anisindione (SHHS1) vs Race
Visit 2
white black native amer/alaskan asian/pacific islander hispanic/mex. amer other Total
Total 3,587 256 8 48 180 1 4,080
No - - - - - - -
Yes - - - - - - -
Unknown 3,587 256 8 48 180 1 4,080